PMID: 6402619Apr 1, 1983Paper

High-dose intravenous immunoglobulin therapy in patients with immune thrombocytopenic purpura

JAMA : the Journal of the American Medical Association
R R CarrollC S Kitchens

Abstract

Four patients with severe chronic immune thrombocytopenic purpura who were refractory to all conventional therapy for that disorder were initially seen with either refractory bleeding or the necessity for an operation. We treated each of these patients with intravenous human serum immunoglobulin, and three of the four patients had a rapid and substantial increase in their platelet counts. This new method for ameliorating chronic immune thrombocytopenic purpura deserves further study and consideration.

Citations

Apr 1, 1989·Transfusion Medicine Reviews·L K Boshkov, J G Kelton
Apr 21, 2009·Clinics in Chest Medicine·Shaunna M Huston, Christopher H Mody
Apr 7, 2004·Mayo Clinic Proceedings·Roberto Stasi, Drew Provan
Feb 10, 2012·Journal of Veterinary Emergency and Critical Care·Reid K NakamuraDomenico Bianco
Mar 1, 1986·Arthritis and Rheumatism·R GoldsteinR J McKendry
Jan 1, 1997·American Journal of Obstetrics and Gynecology·A L Clark, S A Gall
Jan 1, 1986·Critical Reviews in Clinical Laboratory Sciences·E Patten

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.